Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;24(6):617-23.
doi: 10.1002/pon.3683. Epub 2014 Oct 6.

Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline

Affiliations
Review

Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline

Charissa Andreotti et al. Psychooncology. 2015 Jun.

Abstract

Background: Cognitive decline and accompanying neurological changes associated with non-CNS cancer diagnosis and treatment have been increasingly identified in a subset of patients. Initially believed to be because of neurotoxic effects of chemotherapy exposure, observation of cognitive decline in patients not treated with chemotherapy, cancer-diagnosed individuals prior to treatment, and patients receiving alternative treatment modalities (surgery, endocrine therapy, and radiation) has led to the investigation of additional potential etiologies and moderating factors. Stressful experiences have long been posited as a contributor to these cognitive changes. Through reciprocal connectivity with peripheral systems, the brain maintains a dynamic circuitry to adapt to stress (allostasis). However, overuse of this system leads to dysregulation and contributes to pathophysiology (allostatic load). At this time, little research has been conducted to systematically examine the role of allostatic load in cancer-related cognitive dysfunction.

Methods and results: Here, we integrate theories of stress biology, neuropsychology, and coping and propose a model through which individuals with a high level of allostatic load at diagnosis may be particularly vulnerable to the neurocognitive effects of cancer.

Conclusions: Opportunities for future research to test and extend proposed mechanisms are discussed in addition to points of prevention and intervention based on individual variation in stress reactivity and coping skills.

Keywords: cancer; cognition; coping; cortisol; oncology; stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Developmental stress promoting heightened allostatic load may result in diminished cognitive resources underlying adaptive coping with cancer stress and increased risk for cancer related neurocognitive sequelae.

References

    1. Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol. 2012;30(30):3675–86. - PMC - PubMed
    1. Koppelmans V, et al. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat. 2011 - PubMed
    1. de Ruiter MB, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Hum Brain Mapp. 2011 - PMC - PubMed
    1. Schilder CM, et al. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit Rev Oncol Hematol. 2010;76(2):133–41. - PubMed
    1. Olin JJ. Cognitive function after systemic therapy for breast cancer. Oncology (Williston Park) 2001;15(5):613–8. discussion 618, 621–4. - PubMed

Publication types